基本信息
views: 111

Bio
研究方向
课题组围绕心血管及肝脏慢性疾病的发病机制挖掘、药靶发现和相关药物研发开展了广泛研究。重点关注蛋白质质量控制系统特别是细胞自噬在心衰和组织纤维化发病中介导的细胞生物学机制、心血管及肝脏组织异常纤维化的免疫生物学机制、以及靶向蛋白质相互作用的多肽和天然小分子创新药物研发。
课题组围绕心血管及肝脏慢性疾病的发病机制挖掘、药靶发现和相关药物研发开展了广泛研究。重点关注蛋白质质量控制系统特别是细胞自噬在心衰和组织纤维化发病中介导的细胞生物学机制、心血管及肝脏组织异常纤维化的免疫生物学机制、以及靶向蛋白质相互作用的多肽和天然小分子创新药物研发。
Research Interests
Papers共 81 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jinmei Yu, Xusheng Wang, Pengyue Liu,Zhenhe Wang, Jianli Liu, Tian Gan, Ning Xu,Jichao Zhou,Jiaojiao Yu,Hongyu Yuan,Xinchao Ban, Yuanzhen Liu,Xiaowei Zhang,Pingping Li,Bing Cui
biorxiv(2025)
Radiotherapy and oncology journal of the European Society for Therapeutic Radiology and Oncology (2025): 110718-110718
Heart (British Cardiac Society)no. 9 (2025): 391-400
Hongshuai Jia, Guang Yue,Pin Li,Renjun Peng, Ruyue Jin, Yuhan Chen,Hualin Cao, Kangning Yang,Xiaowei Zhang, Xiaoyu Yi, Yangyang Wu, Xiangling Deng, Xiaoye Chen,Lifei Ma, Yang Zhao,Xiaoguang Zhou,Tian Tao, Xiaoli Shen,Xu Zhang,Yuandong Tao,Huixia Zhou
Protein & cell (2025)
ACTA PHARMACEUTICA SINICA Bno. 7 (2024): 3125-3139
Jiao-Jiao Yu, Dan-Dan Zhou,Bing Cui,Cheng Zhang,Feng-Wei Tan, Shan Chang,Ke Li, Xiao-Xi Lv,Xiao-Wei Zhang,Shuang Shang, Yu-Jin Xiang,Fei Chen, Jin-Mei Yu, Shan-Shan Liu,Feng Wang,Zhuo-Wei Hu,Fang Hua
Cancer letterspp.217434-217434, (2024)
Jiaojiao Yu, Yujin Xiang, Yuzhen Gao,Shan Chang, Ren Kong,Xiaoxi Lv,Jinmei Yu, Yunjie Jin, Chenxi Li, Yiran Ma,Zhenhe Wang,Jichao Zhou, Hongyu Yuan,Shuang Shang,Fang Hua,Xiaowei Zhang,Bing Cui,Pingping Li
ACTA PHARMACEUTICA SINICA Bno. 10 (2024): 4378-4395
crossref(2024)
Nature Communicationsno. 1 (2024)
Load More
Author Statistics
#Papers: 81
#Citation: 2763
H-Index: 26
G-Index: 52
Sociability: 6
Diversity: 3
Activity: 51
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn